{
  "docId": "019de515-e1f4-739b-a349-913fc7c75e72",
  "docSlug": "3b70dadd72cd7c3c7226b36c1da9b327",
  "documentTitle": "Allurion | SPAC Presentation Deck | 25 slides",
  "authorId": "allurion",
  "authorName": "Allurion",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 25,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de515-e1f4-739b-a349-913fc7c75e72/9",
  "deckHref": "/decks/019de515-e1f4-739b-a349-913fc7c75e72",
  "deckJsonHref": "/decks/019de515-e1f4-739b-a349-913fc7c75e72.json",
  "deckAnchorHref": "/decks/019de515-e1f4-739b-a349-913fc7c75e72#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.13,
        "w": 0.63,
        "x": 0.189,
        "y": 0.14
      },
      "kind": "image",
      "text": null,
      "attrs": {},
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c3b30195-8ff8-45bf-b7e0-de2898ecc8fa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.279,
        "w": 0.159,
        "x": 0.557,
        "y": 0.316
      },
      "kind": "list",
      "text": "High Costs\n$1,000 per month with limited insurance coverage4",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "527b93f4-529d-45b0-8c0a-efecf37131a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.279,
        "w": 0.159,
        "x": 0.757,
        "y": 0.316
      },
      "kind": "list",
      "text": "Weight Re-Gain\nWeight is re-gained quickly if drugs are stopped5",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa231a1d-0add-476e-a85c-bd5fb73521e3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.385,
        "w": 0.159,
        "x": 0.357,
        "y": 0.316
      },
      "kind": "list",
      "text": "High Risks\nThyroid cancer associated with long-term use2\n9.8% serious adverse event rate3",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e5bc205b-1132-4363-bc05-fd18ce2eaf32",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.44,
        "w": 0.159,
        "x": 0.157,
        "y": 0.316
      },
      "kind": "list",
      "text": "Poor Experience\nWeekly injection\nReal-world drop-out rates of 45-65%1\nLoss of muscle mass3",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee05ea5e-3ccc-43d1-9339-e7ea72e7883a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.85,
        "x": 0.05,
        "y": 0.917
      },
      "kind": "source-note",
      "text": "Sources: 1) Weiss et al. BMJ Open Diab Res and Care 2022:10:e002517. 2) Bezin et al. Diabetes Care 2023;46(2):384-91. 3) Wilding et al. N Engl J Med 2021:384:989-1002. 4) GoodRx, https://www.goodrx.com/wegovy. 5) Wilding et al. Diabetes Obes Metab. 2022;24(8): 1553-64.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "431deb8c-901a-4b1e-822f-1e5c920b5733",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.79,
        "x": 0.079,
        "y": 0.05
      },
      "kind": "title",
      "text": "GLP-1 Drugs Face Several Challenges Allurion Can Capitalize Upon",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fdd79771-2259-46e4-a41f-f45e789a1cf1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "6669392e-2c15-4342-b5c7-9f681bdfa2e5",
      "evidence": "The slide clearly articulates the challenges faced by GLP-1 drugs, using a problem statement format.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 9,
      "from": 6,
      "beatId": "71296a98-68bf-47f9-bf2e-69246aa38cfa",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "Slides 6-9 present the problem statement and challenges with current solutions",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "e850bac4-aef0-4f3b-bd2d-0b6e91fa1886",
      "evidence": "The deck presents the limitations and challenges of current solutions, implying the cost of inaction",
      "position": 0,
      "objective": "What is the cost of not addressing obesity?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}